194 related articles for article (PubMed ID: 31546933)
1. Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies.
Nunes SP; Diniz F; Moreira-Barbosa C; Constâncio V; Silva AV; Oliveira J; Soares M; Paulino S; Cunha AL; Rodrigues J; Antunes L; Henrique R; Jerónimo C
J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31546933
[TBL] [Abstract][Full Text] [Related]
2. A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA.
Salta S; P Nunes S; Fontes-Sousa M; Lopes P; Freitas M; Caldas M; Antunes L; Castro F; Antunes P; Palma de Sousa S; Henrique R; Jerónimo C
J Clin Med; 2018 Nov; 7(11):. PubMed ID: 30405052
[TBL] [Abstract][Full Text] [Related]
3. Cell-Free DNA Methylation of Selected Genes Allows for Early Detection of the Major Cancers in Women.
Nunes SP; Moreira-Barbosa C; Salta S; Palma de Sousa S; Pousa I; Oliveira J; Soares M; Rego L; Dias T; Rodrigues J; Antunes L; Henrique R; Jerónimo C
Cancers (Basel); 2018 Sep; 10(10):. PubMed ID: 30261643
[TBL] [Abstract][Full Text] [Related]
4. HOXA9 gene promotor methylation and copy number variation of SOX2 and HV2 genes in cell free DNA: A potential diagnostic panel for non-small cell lung cancer.
Abou-Zeid A; Hashad D; Baess A; Mosaad M; Tayae E
BMC Cancer; 2023 Apr; 23(1):329. PubMed ID: 37038139
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Diagnostic Potential of Candidate Hypermethylated Genes in Epithelial Ovarian Cancer in North Indian Population.
Singh A; Gupta S; Sachan M
Front Mol Biosci; 2021; 8():719056. PubMed ID: 34778370
[TBL] [Abstract][Full Text] [Related]
6. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.
Pastuszak-Lewandoska D; Kordiak J; Migdalska-Sęk M; Czarnecka KH; Antczak A; Górski P; Nawrot E; Kiszałkiewicz JM; Domańska D; Brzeziańska-Lasota E
Respir Res; 2015 Jun; 16(1):76. PubMed ID: 26112163
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation profiling as a tool for testicular germ cell tumors subtyping.
Costa AL; Moreira-Barbosa C; Lobo J; Vilela-Salgueiro B; Cantante M; Guimarães R; Lopes P; Braga I; Oliveira J; Antunes L; Henrique R; Jerónimo C
Epigenomics; 2018 Dec; 10(12):1511-1523. PubMed ID: 30418048
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNA.
Yang Z; Qi W; Sun L; Zhou H; Zhou B; Hu Y
Adv Clin Exp Med; 2019 Mar; 28(3):355-360. PubMed ID: 30516882
[TBL] [Abstract][Full Text] [Related]
10. High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions.
Martins AT; Monteiro P; Ramalho-Carvalho J; Costa VL; Dinis-Ribeiro M; Leal C; Henrique R; Jerónimo C
Breast Cancer Res Treat; 2011 Aug; 129(1):1-9. PubMed ID: 20842524
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma.
S SK; Swamy SN; Premalatha CS; Pallavi VR; Gawari R
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3001-3005. PubMed ID: 31653147
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
[TBL] [Abstract][Full Text] [Related]
13. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
[No Abstract] [Full Text] [Related]
14. [Meta-analysis of the Association between RASSF1A Gene Promoter Methylation and Non-small Cell Lung Cancer].
Wei H; Fang N; Guo L; Wu Z; Zhou Q
Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):443-50. PubMed ID: 26182870
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of DNA methylation for the detection of cervical and endometrial adenocarcinomas in liquid-based cytology specimens.
Kim GE; Kweon SS; Lee JS; Lee JH; Nam JH; Choi C
Anal Quant Cytopathol Histpathol; 2012 Aug; 34(4):195-203. PubMed ID: 23016466
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).
Niklinska W; Naumnik W; Sulewska A; Kozłowski M; Pankiewicz W; Milewski R
Folia Histochem Cytobiol; 2009; 47(2):275-80. PubMed ID: 19926549
[TBL] [Abstract][Full Text] [Related]
18. Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis.
Ni S; Ye M; Huang T
Oncotarget; 2017 Sep; 8(37):61253-61263. PubMed ID: 28977861
[TBL] [Abstract][Full Text] [Related]
19. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916
[TBL] [Abstract][Full Text] [Related]
20. Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.
Moreira-Barbosa C; Barros-Silva D; Costa-Pinheiro P; Torres-Ferreira J; Constâncio V; Freitas R; Oliveira J; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2018 Oct; 10(1):132. PubMed ID: 30373654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
